Sorafenib, sold under the brand name Nexavar, [3] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver …

2024年3月14日 · What is sorafenib? Sorafenib is used in adults to treat liver cancer, thyroid cancer, or kidney cancer. Sorafenib may also be used for purposes not listed in this …

Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer …

Sorafenib is a medication that stops cancer cells from growing. It treats liver cancer, kidney cancer and thyroid cancer. This medication comes as a tablet that you can take by mouth with …

Tablets containing sorafenib tosylate (274 mg) equivalent to 200 mg of sorafenib. NEXAVAR tablets are round, biconvex, red film-coated tablets, debossed with the “Bayer cross” on one …

2024年7月25日 · Nexavar is a cancer medication that interferes with the growth and spread of cancer cells in the body. Nexavar is used to treat liver cancer, thyroid cancer, or kidney …

Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys).

Medscape - Indication-specific dosing for Nexavar (sorafenib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

Sorafenib is a prescription medicine used in the treatment of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and differentiated thyroid …

2018年6月22日 · Sorafenib is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. Sorafenib has been associated with a low rate of transient …